-
Bictegravir 1611493-60-7
API’s Name Indication Innovator Patent Expiry Date(The U.S) Bictegravir 1611493-60-7 HIV-1 infection Gilead Sciences Dec. 19, 2033 -
Baloxavir Marboxil 1985606-14-1
API’s Name Indication Innovator Patent Expiry Date(The U.S) Baloxavir Marboxil 1985606-14-1 Influenza Shionogi & Roche Sep.21,2031